test
test
test

Marketing
Conferencee 2018

17 - 25 October 2018 | Tobacco Dock, London

REGISTER NOWREGISTER NOW

Aug 24–28
2020

DELIVERED DIGITALLY

Aug 24–28
2020
delivered digitally

Novel Antimicrobials & AMR Diagnostics

4th AMR Conference

AMR Conference

test
test
test

Marketing
Conferencee 2018

17 - 25 October 2018 | Tobacco Dock, London

REGISTER NOWREGISTER NOW

Aug 24–28
2020

DELIVERED DIGITALLY

Aug 24–28
2020
delivered digitally

Novel Antimicrobials & AMR Diagnostics

4th AMR Conference

AMR Conference

test
test
test

Marketing
Conferencee 2018

17 - 25 October 2018 | Tobacco Dock, London

REGISTER NOWREGISTER NOW

Aug 24–28
2020

DELIVERED DIGITALLY

Aug 24–28
2020
delivered digitally

Novel Antimicrobials & AMR Diagnostics

4th AMR Conference

AMR Conference

test
test
test

Marketing
Conferencee 2018

17 - 25 October 2018 | Tobacco Dock, London

REGISTER NOWREGISTER NOW

Aug 24–28
2020

DELIVERED DIGITALLY

Aug 24–28
2020
delivered digitally

Novel Antimicrobials & AMR Diagnostics

4th AMR Conference

AMR Conference

What you can expect

The AMR Conference is a platform to discuss strategies and the specific challenges faced by SMEs in bringing new antimicrobial treatments and diagnostics to market.

More than 400 participants from 25+ countries

High-level panels and expert sessions > live and on-demand

Scientific poster presentations

A wide variety of topics from financing, development & regulation

Virtual 1:1 partnering meetings

SMEs, academics & governmental agencies benefit from discounted fees

2019 Event Highlights

Event Impressions & Testimonials

More than 330 experts joined the 2-day AMR Conference 2019 in Berlin. They called for rapid capital investments and economic incentives in the fight against antimicrobial resistance (AMR). The AMR Conference is a platform for SMEs, start-ups, big pharma, academia, clinicians, investors, public stakeholders and policy-makers to discuss strategies and the specific challenges faced by SMEs in bringing new antimicrobial treatments and diagnostics to the market.

Latest News

in the AMR and antimicrobial space

CARB-X is funding Evotec to develop a new class of broad-spectrum antibiotics

Evotec is the first pharmaceutical R&D company based in Germany in the CARB-X portfolio CARB-X announced…

Cost-efficient and green manufacturing of peptides thanks to Molecular Hiving technology™

Bachem and Jitsubo CO., LTD. recently announced the signature of an exclusive Licensing Agreement for Jitsubo’s…

PBS News Hour story Part II covers recent developments in the AMR field

A remarkable 2-part PBS News Hour story exclusively dedicated to AMR The antibiotics industry has suffered…

We thank our Sponsors & Partners

Supporting Partners

Media Partners